Genesen Labs Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 5.00 M
as on 15-11-2024
- Company Age 42 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.16 Cr
as on 15-11-2024
- Satisfied Charges ₹ 11.99 Cr
as on 15-11-2024
- Revenue -10.00%
(FY 2023)
- Profit -35.76%
(FY 2023)
- Ebitda -19.17%
(FY 2023)
- Net Worth 34.01%
(FY 2023)
- Total Assets -62.81%
(FY 2023)
About Genesen Labs
The Corporate was formerly known as Sanjeevanee Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.16 Cr. The company has closed loans amounting to ₹11.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashwani Khemka, Naina Khemka, and Hitesh Khona serve as directors at the Company.
- CIN/LLPIN
U45200MH1982PLC027861
- Company No.
027861
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1982
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Genesen Labs Limited offer?
Genesen Labs Limited offers a wide range of products and services, including Legal Drafting & Litigation Services, Dispute Resolution Service, Company Law & Labour Law Consultants, Statutory Compliance Services, Project Feasibility Studies, Market Research Service, Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Genesen Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Khemka  | Director | 04-Jan-1991 | Current |
| Naina Khemka | Director | 30-Sep-2009 | Current |
| Hitesh Khona | Director | 25-Mar-1998 | Current |
Financial Performance and Corporate Structure Insights of Genesen Labs.
Genesen Labs Limited, for the financial year ended 2023, experienced in revenue, with a . The company also saw a substantial fall in profitability, with a 35.76% decrease in profit. The company's net worth Soared by an impressive increase of 34.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genesen Labs?
In 2023, Genesen Labs had a promoter holding of 99.95% and a public holding of 0.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Jayanti Sanghvi Creation Date: 30 Dec 2015 | ₹3.00 Cr | Open |
The Saeaswat Co-Op. Bank Ltd. Creation Date: 23 Aug 1986 | ₹0.49 M | Open |
The Maharashtra State Financial Corporation Creation Date: 23 Oct 1985 | ₹0.16 M | Open |
How Many Employees Work at Genesen Labs?
Unlock and access historical data on people associated with Genesen Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genesen Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesen Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
